Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 28 | 2024 | 617 | 7.970 |
Why?
|
| Caenorhabditis elegans Proteins | 18 | 2024 | 396 | 6.570 |
Why?
|
| Immunity, Innate | 17 | 2024 | 766 | 5.510 |
Why?
|
| Pseudomonas aeruginosa | 10 | 2024 | 98 | 2.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 7 | 2024 | 125 | 2.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2023 | 141 | 1.460 |
Why?
|
| Candida albicans | 7 | 2014 | 54 | 1.410 |
Why?
|
| Lysosomes | 2 | 2024 | 162 | 1.110 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2024 | 127 | 1.090 |
Why?
|
| Animals | 31 | 2024 | 19612 | 1.080 |
Why?
|
| Streptococcus bovis | 2 | 2014 | 3 | 0.960 |
Why?
|
| Meningitis, Bacterial | 2 | 2014 | 5 | 0.960 |
Why?
|
| Strongyloides stercoralis | 2 | 2014 | 12 | 0.960 |
Why?
|
| Superinfection | 2 | 2014 | 10 | 0.950 |
Why?
|
| Strongyloidiasis | 2 | 2014 | 10 | 0.950 |
Why?
|
| Antifungal Agents | 4 | 2014 | 117 | 0.940 |
Why?
|
| Streptococcal Infections | 2 | 2014 | 77 | 0.920 |
Why?
|
| Biological Assay | 1 | 2023 | 54 | 0.860 |
Why?
|
| Cryptococcus neoformans | 6 | 2009 | 141 | 0.850 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2020 | 201 | 0.740 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 847 | 0.710 |
Why?
|
| Transcription Factors | 5 | 2023 | 1456 | 0.680 |
Why?
|
| Oleic Acids | 1 | 2019 | 6 | 0.670 |
Why?
|
| Pseudomonas Infections | 4 | 2024 | 50 | 0.650 |
Why?
|
| Molecular Biology | 1 | 2020 | 67 | 0.640 |
Why?
|
| Bacterial Infections | 1 | 2019 | 139 | 0.590 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 73 | 0.590 |
Why?
|
| Intestinal Mucosa | 2 | 2024 | 221 | 0.550 |
Why?
|
| Host-Pathogen Interactions | 2 | 2024 | 239 | 0.550 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 139 | 0.540 |
Why?
|
| MAP Kinase Signaling System | 5 | 2020 | 201 | 0.500 |
Why?
|
| Candidiasis | 4 | 2014 | 40 | 0.480 |
Why?
|
| Membrane Proteins | 2 | 2020 | 843 | 0.480 |
Why?
|
| Evolution, Molecular | 2 | 2014 | 291 | 0.460 |
Why?
|
| Cyclic AMP | 3 | 2005 | 143 | 0.460 |
Why?
|
| Gene Expression Regulation | 5 | 2023 | 1539 | 0.450 |
Why?
|
| Ampicillin | 1 | 2013 | 11 | 0.440 |
Why?
|
| Gentamicins | 1 | 2013 | 22 | 0.430 |
Why?
|
| Listeria monocytogenes | 1 | 2013 | 33 | 0.430 |
Why?
|
| Listeriosis | 1 | 2013 | 30 | 0.430 |
Why?
|
| Activating Transcription Factors | 1 | 2012 | 10 | 0.410 |
Why?
|
| Quinazolines | 1 | 2012 | 22 | 0.410 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2012 | 123 | 0.380 |
Why?
|
| Hypocreales | 1 | 2010 | 1 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 721 | 0.350 |
Why?
|
| Epithelial Cells | 1 | 2012 | 375 | 0.330 |
Why?
|
| Models, Animal | 1 | 2009 | 220 | 0.310 |
Why?
|
| Models, Chemical | 1 | 2009 | 133 | 0.300 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2008 | 12 | 0.300 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2008 | 14 | 0.300 |
Why?
|
| RNA Interference | 4 | 2018 | 591 | 0.300 |
Why?
|
| Drug Discovery | 1 | 2009 | 91 | 0.300 |
Why?
|
| Fungal Proteins | 4 | 2014 | 142 | 0.300 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2008 | 67 | 0.290 |
Why?
|
| Hydrocephalus | 1 | 2008 | 43 | 0.290 |
Why?
|
| Biological Evolution | 2 | 2020 | 109 | 0.250 |
Why?
|
| Melanins | 1 | 2005 | 19 | 0.240 |
Why?
|
| Protein Aggregates | 1 | 2024 | 18 | 0.240 |
Why?
|
| Antigens, Fungal | 1 | 2005 | 54 | 0.240 |
Why?
|
| Sphingolipids | 1 | 2023 | 22 | 0.220 |
Why?
|
| Protein Multimerization | 1 | 2024 | 167 | 0.220 |
Why?
|
| Intestines | 1 | 2024 | 157 | 0.220 |
Why?
|
| Mutation | 4 | 2019 | 2427 | 0.210 |
Why?
|
| Antimalarials | 1 | 2023 | 68 | 0.210 |
Why?
|
| Metformin | 1 | 2023 | 67 | 0.210 |
Why?
|
| NAD+ Nucleosidase | 1 | 2022 | 10 | 0.200 |
Why?
|
| Ligands | 1 | 2023 | 422 | 0.200 |
Why?
|
| Receptors, Cell Surface | 1 | 2024 | 439 | 0.190 |
Why?
|
| NAD | 1 | 2022 | 47 | 0.190 |
Why?
|
| Humans | 11 | 2023 | 59308 | 0.190 |
Why?
|
| Cholesterol | 1 | 2022 | 255 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 204 | 0.180 |
Why?
|
| Receptors, Odorant | 1 | 2020 | 5 | 0.180 |
Why?
|
| Smell | 1 | 2020 | 23 | 0.170 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2020 | 13 | 0.170 |
Why?
|
| Immune System Phenomena | 1 | 2020 | 3 | 0.170 |
Why?
|
| Bacteria | 1 | 2023 | 276 | 0.170 |
Why?
|
| Nematoda | 1 | 2020 | 34 | 0.170 |
Why?
|
| Neurogenesis | 1 | 2020 | 59 | 0.170 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 39 | 0.160 |
Why?
|
| S-Adenosylmethionine | 1 | 2018 | 29 | 0.160 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 53 | 0.150 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 200 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 291 | 0.150 |
Why?
|
| Virulence | 4 | 2014 | 189 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 675 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 350 | 0.130 |
Why?
|
| Disease Resistance | 1 | 2016 | 19 | 0.130 |
Why?
|
| Mitochondria | 1 | 2019 | 333 | 0.130 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 1582 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2016 | 353 | 0.120 |
Why?
|
| Photophobia | 1 | 2014 | 2 | 0.120 |
Why?
|
| Life Cycle Stages | 1 | 2014 | 14 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2014 | 28 | 0.120 |
Why?
|
| Alleles | 1 | 2016 | 425 | 0.120 |
Why?
|
| Prednisone | 1 | 2014 | 80 | 0.120 |
Why?
|
| Exanthema | 1 | 2014 | 27 | 0.120 |
Why?
|
| Headache | 1 | 2014 | 63 | 0.120 |
Why?
|
| Hyphae | 2 | 2014 | 13 | 0.110 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 94 | 0.110 |
Why?
|
| Nausea | 1 | 2014 | 109 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2016 | 367 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2004 | 2890 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1128 | 0.110 |
Why?
|
| Pregnancy Trimester, First | 1 | 2013 | 29 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 148 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2014 | 170 | 0.110 |
Why?
|
| Biofilms | 1 | 2014 | 69 | 0.100 |
Why?
|
| Gene Expression | 1 | 2016 | 808 | 0.100 |
Why?
|
| Phenotype | 1 | 2016 | 1155 | 0.100 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 58 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 895 | 0.100 |
Why?
|
| Genes, Fungal | 1 | 2011 | 54 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2014 | 731 | 0.090 |
Why?
|
| Fungi | 1 | 2011 | 50 | 0.090 |
Why?
|
| Genes, Bacterial | 1 | 2011 | 117 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2013 | 5141 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 158 | 0.090 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2010 | 54 | 0.090 |
Why?
|
| Receptors, Scavenger | 1 | 2009 | 9 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2009 | 171 | 0.080 |
Why?
|
| Cryptococcosis | 2 | 2009 | 71 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 697 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 281 | 0.070 |
Why?
|
| Adult | 2 | 2014 | 15731 | 0.070 |
Why?
|
| DNA Primers | 2 | 2005 | 291 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 2062 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 500 | 0.070 |
Why?
|
| Pregnancy | 1 | 2013 | 2352 | 0.060 |
Why?
|
| Patient Selection | 1 | 2008 | 445 | 0.060 |
Why?
|
| Genotype | 2 | 2005 | 644 | 0.060 |
Why?
|
| Laccase | 1 | 2005 | 3 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2005 | 7 | 0.060 |
Why?
|
| Gene Duplication | 1 | 2005 | 32 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2005 | 9 | 0.060 |
Why?
|
| Blotting, Southern | 1 | 2005 | 52 | 0.060 |
Why?
|
| Genome, Fungal | 1 | 2005 | 40 | 0.060 |
Why?
|
| Translocation, Genetic | 1 | 2005 | 64 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 148 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2005 | 166 | 0.060 |
Why?
|
| Male | 2 | 2014 | 27482 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 282 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2005 | 321 | 0.060 |
Why?
|
| Ethyl Ethers | 1 | 2023 | 1 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2005 | 253 | 0.060 |
Why?
|
| Ethers | 1 | 2023 | 17 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 704 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 525 | 0.050 |
Why?
|
| Species Specificity | 1 | 2004 | 336 | 0.050 |
Why?
|
| Oxygen | 1 | 2005 | 307 | 0.050 |
Why?
|
| Mice | 4 | 2014 | 10256 | 0.050 |
Why?
|
| Longevity | 1 | 2023 | 111 | 0.050 |
Why?
|
| Adenylyl Cyclases | 1 | 2002 | 21 | 0.050 |
Why?
|
| RNA | 1 | 2005 | 404 | 0.050 |
Why?
|
| Lipids | 1 | 2023 | 305 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 418 | 0.040 |
Why?
|
| Female | 3 | 2013 | 30805 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1470 | 0.040 |
Why?
|
| Histone Code | 1 | 2018 | 25 | 0.040 |
Why?
|
| Genes, Helminth | 1 | 2018 | 53 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2018 | 32 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 34 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 193 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 281 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2019 | 280 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 3567 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 209 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2018 | 185 | 0.030 |
Why?
|
| Transcriptome | 1 | 2019 | 324 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 2014 | 15 | 0.030 |
Why?
|
| Moths | 1 | 2014 | 23 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 759 | 0.030 |
Why?
|
| Cell Wall | 1 | 2014 | 113 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2014 | 183 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 394 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 880 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2014 | 603 | 0.020 |
Why?
|
| CD36 Antigens | 1 | 2009 | 26 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2009 | 211 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 119 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 220 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 553 | 0.020 |
Why?
|
| Chromosomes, Fungal | 1 | 2005 | 35 | 0.020 |
Why?
|
| Cytokines | 1 | 2009 | 906 | 0.020 |
Why?
|
| Telomere | 1 | 2005 | 47 | 0.010 |
Why?
|
| Macrophages | 1 | 2009 | 1006 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 853 | 0.010 |
Why?
|
| Reproduction | 1 | 2002 | 88 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 1977 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 385 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 1312 | 0.010 |
Why?
|
Pukkila-Worley's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(191)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_